Let’s Talk Medtech

In this episode of Let's Talk Medtech, host Omar Ford sits down with Rocco De Bernardis, Global President of Soft Tissue Robotics at Johnson & Johnson MedTech, to discuss the recent FDA De Novo authorization of the Ottava robotic surgical system.The two dive into Ottava's origin story — from its roots in a Verily Life Sciences partnership to years of acquisitions and internal development — and explore how J&J is positioning the system not just as a single device, but as an expanding ecosystem spanning advanced instrumentation, digital integration through Polyphonic, and future automation and AI capabilities.He also outlines J&J's roadmap for new indications beyond the initial ten approved procedures, including an ongoing inguinal hernia trial and future expansion into urology and gynecology, as well as plans to bring Ottava to markets in Europe and Asia.The conversation closes with a candid look at the broader robotic-assisted surgery market — still only 9% globally penetrated — and what it will take for J&J to compete with established players like Intuitive Surgical, plus a breakdown of what makes Ottava's compact, table-integrated design and automation-ready architecture stand apart.

Join us as we sit down with Quentin Blackford, CEO of iRhythm Technologies, for an exclusive conversation that dives deep into the seismic shifts reshaping cardiac monitoring.🔥 What's on the table?Blackford pulls back the curtain on iRhythm's plan to acquire VitalConnect. Discover the vision behind this bold expansion and what it means for the future of remote patient monitoring.But that's just the beginning. We're exploring how cutting-edge AI technology is supercharging the legendary Zio Patch, transforming raw cardiac data into life-saving insights.Blackford opens up about iRhythm's recovery from a recent cyberattack—sharing hard-won lessons on resilience, security, and what it takes to bounce back stronger than ever in today's digital healthcare landscape.This is the conversation everyone in medtech will be talking about. Don't miss it!🎧 Let's Talk Medtech — where innovation meets insight.

In this episode of Let's Talk Medtech, Jim Hollingshead, CEO of BVI, joins host Omar Ford to discuss his fascinating career journey and his vision for transforming eye surgery through cutting-edge medical technology.

In this episode, we sit down with Logan McKnight, the founder of GoodKnight Consulting, to explore her nearly 20-year journey through the medtech industry—from neuromonitoring and spinal devices to witnessing groundbreaking innovations like intraoperative imaging transform the operating room.After stepping down as CEO in 2023, she launched her consulting practice with a mission: bridging the persistent disconnect between corporate teams and field sales that prevents medtech companies from reaching their full potential.We dive into why communication breakdowns and siloed thinking plague the industry, how she helps small-to-medium-sized companies build unified leadership cultures, and the critical moment when founders must let go of control to scale successfully.Whether you're navigating post-commercial growth, struggling with team alignment, or wondering when to bring in outside expertise, this conversation offers honest insights into what it really takes to turn innovative medical devices into market success.

Tariffs, consolidation, and inflation are transforming medical device manufacturing. Wipfli's Cara Walton discusses how these industry trends are reshaping production processes and what medtech companies can do to stay ahead.

In just the past two months, Stryker, Intuitive Surgical, and Medtronic – three of the world's Top 100 Medical Device companies – have faced cyberattacks. Why are medtech companies becoming prime targets for hackers? What makes medical devices so vulnerable? And how is the FDA responding? In this episode of Let's Talk Medtech, Naomi Schwartz, VP of Regulatory Strategy at Medcrypt, breaks down: ✅ The anatomy of recent cyberattacks on leading medtech firms ✅ Why hackers are targeting the medical device industry ✅ What these breaches mean for patient safety and data security ✅ FDA's new cybersecurity requirements and what companies must do now

Discover how iRhythm is changing arrhythmia detection and patient care with CFO Daniel Wilson. In this episode of "Let's Talk MedTech," we explore the groundbreaking Zio monitor, a wearable device that uses FDA-cleared AI to provide continuous 14-day heart monitoring. Learn how iRhythm Technologies is addressing the challenges of undiagnosed arrhythmias, expanding into primary care, and even venturing into sleep disorder diagnostics. With nearly 3 million patients served annually and more than 140 peer-reviewed studies, iRhythm is at the forefront of predictive healthcare. Subscribe for more insights into the medical device and diagnostics industry! #MedTech #iRhythm #AI #Wearables #HealthcareInnovation

Holley Miller, founder and President of Grey Matter Marketing, is our guest on this episode of Let's Talk Medtech to discuss why it's so crucial to have the right message for your product.

Join Marissa Fayer, CEO of HerHealthEQ and DeepLook Medical, as she explores the future of women's health and what it could look like in 2026 in this insightful episode of Let's Talk Medtech.

Augurex is a commercial-stage diagnostics company dedicated to the early identification and diagnosis of autoimmune disorders, enabling the optimization and personalization of treatment options for patients. Neil Klompas, the firm’s CEO, joins us for this episode of Let’s Talk Medtech to discuss how the company aims to accelerate the diagnosis of the disease and enhance autoimmune diagnostics for patients.